Marcia A. Munoz

Garvan Institute of Medical Research — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index1.6kcitations55works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(14), Bone health and treatments(7), Cancer therapeutics and mechanisms(6), Neuroblastoma Research and Treatments(6), Inflammasome and immune disorders(5)

Publications54 total

NLRP3 is a thermosensor that is negatively regulated by high temperature
2025· 1 citedOpen Access
Supplementary Video 2 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 1 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 4 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Video Legends.Supplementary Table 1. Supplementary Figure 5 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 3 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 4 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Data from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 2 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Data from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Video Legends.Supplementary Table 1. Supplementary Figure 5 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 3 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Supplementary Video 1 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
2023Open Access
Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency
Journal of Clinical Investigation·2022· 11 citedOpen Access
Increased core body temperature exacerbates defective protein prenylation in mouse avatars of mevalonate kinase deficiency
2022Open Access
Author response: Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages
2021Open Access
Cellular and molecular actions of bisphosphonates
Elsevier eBooks·2021· 1 cited
Bisphosphonate drugs have actions outside the skeleton and inhibit the mevalonate pathway in alveolar macrophages
2021Open Access
Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton
Bone·2020· 175 cited
Bisphosphonates and Bone Cells—Molecular Mechanisms
Elsevier eBooks·2020· 1 cited
page 1 of 3Next →

Frequent Co-authors

Michael J. Rogers(12), Eddy Pasquier(12), Snega Sinnappan(12), Maria Kavallaris(12), Julie Jurczyluk(10), Michelle J. Henderson(8), Oliver P. Skinner(7), Sam Mehr(7), Michelle Haber(6), Murray D. Norris(6), Wolfgang Weninger(5), Claudia L. Flemming(5), Amanda J. Russell(5), Anna Simon(5), Jamie I. Fletcher(4), Mario Cantín(4), Sérgio Olate(4), Esther Kristianto(4), Mark P. Hodson(4), Antônio Porro(3)